About
InCephalo Therapeutics develops compartment-locked biologic therapies that enable targeted and safe treatment of glioblastoma and other CNS diseases by confining cytokine activation locally within the brain to avoid systemic toxicity.
Explore InCephalo Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.